These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 8284542

  • 21. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR, Pose Reino A, Román AV, García Acuña JM, Fernández López JA, Cerrato JC.
    Am J Cardiol; 1997 Feb 01; 79(3):373-6. PubMed ID: 9036764
    [Abstract] [Full Text] [Related]

  • 22. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.
    Seara FJ, Juanatey JR, Sande JL, Veloso PR, Reino AP, Román AV, Cerrato JC, Peña MG.
    Ann Noninvasive Electrocardiol; 2003 Jan 01; 8(1):47-54. PubMed ID: 12848813
    [Abstract] [Full Text] [Related]

  • 23. Step-down of enalapril treatment for arterial hypertension.
    González-Juanatey JR, Reino AP, García-Acuña JM, González-Juanatey C, Valdes L, Cabezas-Cerrato J.
    Hypertension; 1999 Dec 01; 34(6):1287-92. PubMed ID: 10601132
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Regression of left ventricular hypertrophy from systemic hypertension by enalapril.
    Nakashima Y, Fouad FM, Tarazi RC.
    Am J Cardiol; 1984 Apr 01; 53(8):1044-9. PubMed ID: 6322566
    [Abstract] [Full Text] [Related]

  • 27. [Effect of tetrandrine and verapamil on left ventricular diastolic and systolic function in essential hypertension].
    Zeng B, Dai GZ.
    Zhonghua Nei Ke Za Zhi; 1991 Mar 01; 30(3):134-7, 187. PubMed ID: 1874078
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
    González-Juanatey JR, Reino AP, García-Acuña JM, Varela Román A, Calvo Gómez C, Cabezas-Cerrato J.
    Am J Cardiol; 1998 Jan 01; 81(1):87-90. PubMed ID: 9462614
    [Abstract] [Full Text] [Related]

  • 30. Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension.
    Yamakado T, Teramura S, Oonishi T, Maeda M, Nakano T.
    Clin Cardiol; 1994 Nov 01; 17(11):615-8. PubMed ID: 7834936
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effects of antihypertensive therapy with enalapril maleate on morphological and functional parameters of the left ventricle in hypertensive subjects].
    Wu SC, Secchi MB, Mancarella S, Bettazzi L, Civelli M, Cirò A, Oltrona L, Folli G.
    Cardiologia; 1985 Jul 01; 30(7):537-42. PubMed ID: 3011265
    [No Abstract] [Full Text] [Related]

  • 33. [The regression of the structural-functional changes in the hypertrophic left ventricle during the long-term correction of the arterial pressure with Inhibace (cilazapril)].
    Gurochkin AB, Ivleva AIa, Kobavlava ZhD, Moiseev VS.
    Ter Arkh; 1994 Jul 01; 66(9):46-9. PubMed ID: 7992212
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Left ventricular hypertrophy: what lies beneath?
    Rubiś PP.
    Pol Arch Intern Med; 2019 Dec 23; 129(12):945-948. PubMed ID: 31868864
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of enalapril on left ventricular hypertrophy and left ventricular function in patients with hypertension].
    Kakinoki S, Takechi S, Hashimoto M, Sakuma I, Nomura A, Kitabatake A, Yasuda H.
    Kokyu To Junkan; 1993 Dec 23; 41(12):1185-9. PubMed ID: 8284542
    [Abstract] [Full Text] [Related]

  • 39. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan 23; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.